Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original application for Montelukast Sodium (generic) from Rising Pharma Holdings, expanding access to montelukast prod…
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's Montelukast Sodium as an original generic application (ANDA 201515).
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies [Phase 3]
A Phase 3 trial evaluating a nasal spray for seasonal allergic rhinitis has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of ciclesonide HFA nasal aerosol for seasonal allergic rhinitis triggered by mounta…
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial evaluated the efficacy and safety of ciclesonide HFA nasal aerosol for seasonal allergic rhinitis; the study was co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis [Phase 2]
Phase II trial evaluating intranasal GSK256066 in combination with azelastine hydrochloride for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber [Phase 2]
Phase 2 trial comparing GSK256066 to placebo in allergic rhinitis patients using a pollen challenge chamber has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 clinical trial in adults and adolescents with seasonal allergic rhinitis (hay fever) completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR [Phase 2]
Phase 2 study assessing the efficacy and safety of Beclomethasone dipropionate HFA nasal aerosol in patients 12 years and older with seasona…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis [Phase 3]
This document reports the completion of a Phase 3 efficacy trial evaluating symptomatic treatment for seasonal allergic rhinitis sponsored b…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber [Phase 2]
This Phase 2 randomized, double-blind, four-way crossover trial assesses the efficacy of Bilastine for Seasonal Allergic Rhinitis; the study…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine [Phase 3]
This entry summarizes a Phase 3 trial evaluating bilastine for symptomatic treatment of seasonal allergic rhinitis, with study status listed…
-
CLINICAL_TRIALS trial_result · 2012-03-21Clinical Trial Update: Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy [Phase 4]
A Phase 4 trial comparing perennial and preseasonal subcutaneous immunotherapy for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Twin SUBLIVAC® Grasses Clinical Efficacy Study [Phase 3]
Phase 3 clinical efficacy study of Twin SUBLIVAC Grasses for seasonal allergic rhinitis and allergic conjunctivitis. The study status is com…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: SUBLIVAC® Birch PROBE Study [Phase 2]
A Phase 2 trial of SUBLIVAC Birch PROBE for birch pollen allergy and seasonal allergic rhinitis has completed.
-
FDA approval · 2012-02-03FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochlori…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation [Phase 1, Phase 2]
Teva-sponsored Phase 1/2 study completed evaluating the clinical equivalence of Mometasone Nasal Spray 50 mcg/actuation for seasonal allergi…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: MOA Study of Ze 339 in Seasonal Allergic Rhinitis [Phase 2]
Phase 2 MOA study of Ze 339 for seasonal allergic rhinitis has completed; the update does not include study results.
-
CLINICAL_TRIALS trial_result · 2012-01-25Clinical Trial Update: Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis [Phase 3]
Phase 3 trial evaluating a combination of olopatadine hydrochloride and ketorolac tromethamine in an ophthalmic solution versus olopatadine …
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy [Phase 3]
Phase 3 trial comparing different schedules of sublingual immunotherapy for pollen allergy has completed, evaluating efficacy and safety of …
-
FDA approval · 2011-12-16FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC. The approval updates the product labeli…
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy [Phase 4]
Phase 4 clinical trial update evaluating regulatory lymphocytes in patients treated with specific immunotherapy for seasonal allergic rhinit…
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 safety trial evaluating grass pollen-derived peptides for seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents [NA]
A completed study assessing the safety and efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in children and adolescents w…
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of a nasal spray for seasonal allergic rhinitis has completed.